These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 16207846)

  • 41. Association of MBL2, TGF-beta1 and CD14 gene polymorphisms with lung disease severity in cystic fibrosis.
    Faria EJ; Faria IC; Ribeiro JD; Ribeiro AF; Hessel G; Bertuzzo CS
    J Bras Pneumol; 2009 Apr; 35(4):334-42. PubMed ID: 19466271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor.
    King SJ; Topliss DJ; Kotsimbos T; Nyulasi IB; Bailey M; Ebeling PR; Wilson JW
    Eur Respir J; 2005 Jan; 25(1):54-61. PubMed ID: 15640323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis.
    Arkwright PD; Laurie S; Super M; Pravica V; Schwarz MJ; Webb AK; Hutchinson IV
    Thorax; 2000 Jun; 55(6):459-62. PubMed ID: 10817792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL1B polymorphisms modulate cystic fibrosis lung disease.
    Levy H; Murphy A; Zou F; Gerard C; Klanderman B; Schuemann B; Lazarus R; García KC; Celedón JC; Drumm M; Dahmer M; Quasney M; Schneck K; Reske M; Knowles MR; Pier GB; Lange C; Weiss ST
    Pediatr Pulmonol; 2009 Jun; 44(6):580-93. PubMed ID: 19431193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype.
    Kerem E; Nissim-Rafinia M; Argaman Z; Augarten A; Bentur L; Klar A; Yahav Y; Szeinberg A; Hiba O; Branski D; Corey M; Kerem B
    Pediatrics; 1997 Sep; 100(3):E5. PubMed ID: 9271620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function.
    Simmonds NJ; D'Souza L; Roughton M; Alton EW; Davies JC; Hodson ME
    Eur Respir J; 2011 May; 37(5):1076-82. PubMed ID: 20847077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection.
    Park JE; Yung R; Stefanowicz D; Shumansky K; Akhabir L; Durie PR; Corey M; Zielenski J; Dorfman R; Daley D; Sandford AJ
    Genes Immun; 2011 Jul; 12(5):370-7. PubMed ID: 21270830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease.
    Frangolias DD; Ruan J; Wilcox PJ; Davidson AG; Wong LT; Berthiaume Y; Hennessey R; Freitag A; Pedder L; Corey M; Sweezey N; Zielenski J; Tullis E; Sandford AJ
    Am J Respir Cell Mol Biol; 2003 Sep; 29(3 Pt 1):390-6. PubMed ID: 12689922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients.
    Hubert D; Bienvenu T; Desmazes-Dufeu N; Fajac I; Lacronique J; Matran R; Kaplan JC; Dusser DJ
    Eur Respir J; 1996 Nov; 9(11):2207-14. PubMed ID: 8947061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic modifiers in cystic fibrosis.
    Stanke F; Tümmler B; Becker T
    N Engl J Med; 2006 Jan; 354(1):88-90; author reply 88-90. PubMed ID: 16394309
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study.
    McKone EF; Emerson SS; Edwards KL; Aitken ML
    Lancet; 2003 May; 361(9370):1671-6. PubMed ID: 12767731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients.
    Crovella S; Segat L; Amato A; Athanasakis E; Bezzerri V; Braggion C; Casciaro R; Castaldo G; Colombo C; Covone AE; De Rose V; Gagliardini R; Lanzara C; Minicucci L; Morgutti M; Nicolis E; Pardo F; Quattrucci S; Raia V; Ravazzolo R; Seia M; Stanzial V; Termini L; Zazzeron L; Cabrini G; Gasparini P
    Clin Chem Lab Med; 2011 Jan; 49(1):49-54. PubMed ID: 21077791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patients.
    Melotti P; Mafficini A; Lebecque P; Ortombina M; Leal T; Pintani E; Pepermans X; Sorio C; Assael BM
    PLoS One; 2014; 9(12):e114274. PubMed ID: 25503271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine gene polymorphisms and severity of CF lung disease.
    de Vries L; Griffiths A; Armstrong D; Robinson PJ
    J Cyst Fibros; 2014 Dec; 13(6):699-705. PubMed ID: 24853301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiological analysis of children with cystic fibrosis who are homozygous for cystic fibrosis transmembrane conductance regulator mutation S549R (T-->G).
    Frossard PM; Bakalinova D; Hertecant J; Bossaert Y; Dawson KP
    J Trop Pediatr; 1999 Jun; 45(3):158-60. PubMed ID: 10401194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung disease.
    Kormann MS; Hector A; Marcos V; Mays LE; Kappler M; Illig T; Klopp N; Zeilinger S; Carevic M; Rieber N; Eickmeier O; Zielen S; Gaggar A; Moepps B; Griese M; Hartl D
    Eur Respir J; 2012 Jun; 39(6):1385-90. PubMed ID: 22088968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mannose-binding lectin gene as a modifier of the cystic fibrosis phenotype in Argentinean pediatric patients.
    Gravina LP; Crespo C; Giugno H; Sen L; Chertkoff L; Mangano A; Castaños C
    J Cyst Fibros; 2015 Jan; 14(1):78-83. PubMed ID: 25178872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis.
    McCague AF; Raraigh KS; Pellicore MJ; Davis-Marcisak EF; Evans TA; Han ST; Lu Z; Joynt AT; Sharma N; Castellani C; Collaco JM; Corey M; Lewis MH; Penland CM; Rommens JM; Stephenson AL; Sosnay PR; Cutting GR
    Am J Respir Crit Care Med; 2019 May; 199(9):1116-1126. PubMed ID: 30888834
    [No Abstract]   [Full Text] [Related]  

  • 59. Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism.
    Plant BJ; Gallagher CG; Bucala R; Baugh JA; Chappell S; Morgan L; O'Connor CM; Morgan K; Donnelly SC
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1412-5. PubMed ID: 16179637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease.
    Collaco JM; Vanscoy L; Bremer L; McDougal K; Blackman SM; Bowers A; Naughton K; Jennings J; Ellen J; Cutting GR
    JAMA; 2008 Jan; 299(4):417-24. PubMed ID: 18230779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.